Journal of VirologyMicrobiologyPeer-reviewed journal article
Comparative study on the virulence of mycobacteriophages
Ilaria RubinoiD, Carlos A. Guerrero-BustamanteiD, Melissa Harrison, Sheila Co, Isobel Tetreau, Mani OrdoubadiiD, Sasha E. LarseniD, Rhea N. ColeriD, Reinhard VehringiD, Graham F. HatfulliD, Dominic SauvageauiD
Abstract
The global tuberculosis (TB) epidemic affected 10 million people and caused 1.3 million deaths in 2022 alone. Multidrug-resistant TB is successfully treated in less than 60% of cases by long, expensive and aggressive treatments. Mycobacteriophages, viruses that can infect bacteria such as Mycobacterium tuberculosis--the species responsible for TB, have the potential to redefine TB prevention and treatments. However, the development of phage-based products necessitates the assessment of numerous parameters, including virulence and adsorption, to ensure their performance and quality. In this work, we characterized the virulence of three different mycobacteriophages (Fionnbharth, Muddy and D29), alone and as cocktails, against a TB model host (Mycobacterium smegmatis) under planktonic and early-stage biofilm growth conditions. Phage D29 and cocktails containing D29 had the highest virulence under all conditions. Interestingly, phages Fionnbharth and Muddy and their combination showed higher virulence against early-stage biofilm than against the planktonic phenotype. Adsorption assays indicated that all three phages had lower adsorption efficiencies on the early-stage biofilm phenotype than on the planktonic one, suggesting a reduced availability of receptors in the former. Given that, despite these lower adsorption efficiencies, the virulence of the phages and phage cocktails was either unchanged or higher against the early-stage biofilm, this phenotype must display properties that are favorable to other steps of the infection process. These results inform us on the dynamics of mycobacteriophage infections, alone and in cocktail formulations, under different host growth conditions, and serve as a basis for the development of phage products targeting mycobacteria biofilms.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 6th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antimycobacterial potential of Mycobacteriophage under disease-mimicking conditions
Y. C. Kalapala, P. R. Sharma, R. Agarwal·bioRxiv·May 16, 2020
- Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions
Saskia Janssen, Sasha E. Larsen, … Jakko van Ingen·bioRxiv·May 11, 2026
- Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice
- Mycobacterium trehalose polyphleates are required for infection by therapeutically useful mycobacteriophages BPs and Muddy
K. S. Wetzel, M. Illouz, … L. Kremer·bioRxiv·Mar 14, 2023
- Inactivating conditions of therapeutic mycobacteriophages
Andrew G. Wiggins, Umar Chaudhry, … Miriam Braunstein·Microbiology SpectrumPeer-reviewed·Feb 11, 2026
- A holistic insight of mycobacteriophage induced changes in mycobacterial cells
Fatema Calcuttawala, Rahul Shaw, … S. K. GUPTA·bioRxiv·Oct 21, 2021